<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Epstein-Barr virus (EBV) causes <z:e sem="disease" ids="C0021345" disease_type="Disease or Syndrome" abbrv="">infectious mononucleosis</z:e> and is associated with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> in immunocompromised populations </plain></SENT>
<SENT sid="1" pm="."><plain>EBV establishes a <z:e sem="disease" ids="C0872054" disease_type="Disease or Syndrome" abbrv="">latent infection</z:e> and immortalizes and transforms B lymphocytes </plain></SENT>
<SENT sid="2" pm="."><plain>Several latent proteins have profound effects on cellular growth, including activation of NF-kappaB, phosphatidylinositol 3'-OH kinase (PI3K) signaling, and notch signaling </plain></SENT>
<SENT sid="3" pm="."><plain>Activation of PI3K can affect the activity of beta-catenin, the target of the wnt signaling pathway </plain></SENT>
<SENT sid="4" pm="."><plain>Deregulation of beta-catenin is associated with a number of <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>To determine if beta-catenin is regulated by <z:e sem="disease" ids="C0149678" disease_type="Disease or Syndrome" abbrv="">EBV infection</z:e>, EBV-infected cells were examined for beta-catenin levels and localization </plain></SENT>
<SENT sid="6" pm="."><plain>beta-Catenin was increased in EBV-positive <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell lines compared to EBV-negative lines, in EBV-infected Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cell lines, and in EBV-transformed lymphoblastoid cell lines (LCL) </plain></SENT>
<SENT sid="7" pm="."><plain>In contrast to wnt signaling, EBV consistently induced the accumulation of beta-catenin in the cytoplasm but not the nucleus </plain></SENT>
<SENT sid="8" pm="."><plain>The beta-catenin regulating kinase, <z:chebi fb="15" ids="28087">glycogen</z:chebi> synthase kinase 3beta (GSK3beta), was shown to be phosphorylated and inactivated in EBV-infected lymphocytes </plain></SENT>
<SENT sid="9" pm="."><plain>Inactivated GSK3beta was localized to the nucleus of EBV-infected LCL </plain></SENT>
<SENT sid="10" pm="."><plain>Neither the cytoplasmic accumulation of beta-catenin nor the nuclear inactivation of GSK3beta was affected by the inhibition of PI3K signaling </plain></SENT>
<SENT sid="11" pm="."><plain>These data indicate that <z:e sem="disease" ids="C0872054" disease_type="Disease or Syndrome" abbrv="">latent infection</z:e> with EBV has unique effects on beta-catenin signaling that are distinct from activation of wnt and independent of its effects on PI3K </plain></SENT>
</text></document>